O-2545

From Wikipedia, the free encyclopedia
Jump to: navigation, search
O-2545
O-2545.svg
Systematic (IUPAC) name
(6aR,10aR)-6a,7,10,10a-Tetrahydro-3-[5-(1H-imidazol-1-yl)-1,1-dimethylpentyl]-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol
Clinical data
Legal status
  • Unscheduled
Identifiers
CAS number 874745-42-3 YesY
ATC code ?
ChemSpider 22938186 N
Chemical data
Formula C26H36N2O2 
Mol. mass 408.575 g/mol
 N (what is this?)  (verify)

O-2545 is an analgesic cannabinoid derivative created by Organix Inc. for use in scientific research. Unlike most cannabinoids discovered to date, it is water soluble, which gives it considerable advantages over many related cannabinoids. It has high affinity for both CB1 and CB2 receptors, with Ki values of 1.5nM at CB1 and 0.32nM at CB2.[1]


See also[edit]

References[edit]

  1. ^ Martin BR, et al. Pharmacological characterization of novel water-soluble cannabinoids. Journal of Pharmacology and Experimental Therapeutics. 2006 Sep;318(3):1230-9. PMID 16757541